Page last updated: 2024-10-30

mesalamine and Hemoglobinuria, Paroxysmal

mesalamine has been researched along with Hemoglobinuria, Paroxysmal in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Hemoglobinuria, Paroxysmal: A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kidoguchi, K1
Kubota, Y1
Fujimoto, S1
Sakata, Y1
Kizuka-Sano, H1
Yamaguchi, K1
Ureshino, H1
Katsuya, H1
Ando, T1
Esaki, M1
Kimura, S1

Other Studies

1 other study available for mesalamine and Hemoglobinuria, Paroxysmal

ArticleYear
Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome.
    Internal medicine (Tokyo, Japan), 2021, Volume: 60, Issue:10

    Topics: Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Histocompatibility Antigens Class I; Humans; Intestina

2021